Organization | CureSearch

CureSearch Report issue

Foundation Phase 1

Founded: Bethesda MD United States (1987)

Organization Overview

First Clinical Trial

2020

NCT04196413

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

CureSeach | CureSearch

Active Ingredients

Drugs in Phase 1 Trials (4)

autologous total tumor mrna and pp65 full length (fl) lysosomal associated membrane protein (lamp) mrna loaded dotap liposome vaccine administered intravenously (rna loaded lipid particles, rna-lps) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

fludarabine (fludara) (1 trial)

gd2 car t cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Glioma (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 2
# of Trial APIs: 4